The Role of Surrogate Endpoints in Clinical Trials - Donald E. Cutlip, MD

↳ This is a section part of Moment: CRT 2015 Atherosclerosis & Research - Clinical Trial Interpretation: Pitfalls and Practical Lessons

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

The Role of Surrogate Endpoints in Clinical Trials presented by Donald E. Cutlip, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physiology technicians
  • Nurses and other allied healthcare professionals 

Session Name: Clinical Trial Interpretation: Pitfalls and Practical Lessons

Track: Atherosclerosis & Research

Learning Objectives

  • The latest updates in Atherosclerosis and the Essentials of Clinical Research

Other Components in this Moment

Overview
Registry-Based Randomized Trials - Mitchell W. Krucoff, MD
Subgroup Analyses and Data Interpretation - Daniel A. Canos, MPH
Practicalities and Misapplications of Composite Endpoints in Clinical Trials - Ajay J. Kirtane, MD
The Role of Surrogate Endpoints in Clinical Trials - Donald E. Cutlip, MD
Non-Inferiority Exposed: Uses and Abuses - Ajay J. Kirtane, MD
Loading Simple Education